(Q46832039)

English

Comparative antimicrobial potency of meropenem tested against Gram-negative bacilli: report from the MYSTIC surveillance program in the United States (2004).

scientific article published in October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16323433

Comparative antimicrobial potency of meropenem tested against Gram-negative bacilli: report from the MYSTIC surveillance program in the United States (2004). (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16323433

Gram-negative bacteria

0 references

United States of America

0 references

1 reference

based on heuristic

inferred from title

4

object named as

Jones RN

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16323433

author name string

Rhomberg PR

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16323433

Fritsche TR

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16323433

Sader HS

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16323433

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16323433

Journal of Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16323433

17

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16323433

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16323433

459-469

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16323433

Antimicrobial susceptibility of community-acquired respiratory tract pathogens in North America in 1999-2000: findings of the PROTEKT surveillance study

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.459

21 January 2018

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.459

21 January 2018

A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: the Alexander Project

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.459

21 January 2018

MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): a global overview

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.459

21 January 2018

Determining the value of antimicrobial surveillance programs

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.459

21 January 2018

Emerging epidemic of metallo-beta-lactamase-mediated resistances.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.459

21 January 2018

Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.459

21 January 2018

Appearance of IMP-1 metallo-beta-lactamase in Europe.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.459

21 January 2018

Emergence in Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the VIM-4 metallo-beta-lactamase encoded by a conjugative plasmid.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.459

21 January 2018

Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.459

21 January 2018

Susceptibility of meropenem and comparators tested against 30,634 Enterobacteriaceae isolated in the MYSTIC Programme (1997-2003).

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.459

21 January 2018

Bacteraemia in Europe--antimicrobial susceptibility data from the MYSTIC surveillance programme

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.459

21 January 2018

blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.459

21 January 2018

The need for new antibiotics

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.459

21 January 2018

Identifiers

10.1179/JOC.2005.17.5.459

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16323433

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16323433

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46832039&oldid=2168124329"